Skip to content

Bio-Rad Laboratories BIO Total Current Assets

Total Current Assets at other companies

Abbott logo
AbbottABT
$25.51B+10.2%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$8.01B-7.5%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$22.32B-4.5%
Danaher logo
DanaherDHR
$13.94B+46.3%
Revvity logo
RevvityRVTY
$2.13B-8.2%
Agilent Technologies logo
Agilent TechnologiesA
$4.76B+13.2%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories's total current assets?
Bio-Rad Laboratories (BIO) reported total current assets of $2.94B in Q1 2026.
How has Bio-Rad Laboratories's total current assets changed year-over-year?
Bio-Rad Laboratories's total current assets decreased by 3.1% year-over-year, from $3.04B to $2.94B.
What is the long-term trend for Bio-Rad Laboratories's total current assets?
Over 5 years (2020 to 2025), Bio-Rad Laboratories's total current assets has grown at a 6.3% compound annual growth rate (CAGR), from $2.14B to $2.91B.
What does total current assets mean?
The sum of all assets that the company expects to turn into cash within one year.
How do you interpret total current assets?
An increase generally indicates improved short-term liquidity, while a consistent decrease may signal potential cash flow constraints.
How does total current assets compare across companies?
Used universally to calculate the current ratio; peers in life sciences typically maintain robust current asset levels.